Logo image of OPK

OPKO HEALTH INC (OPK) Stock Price, Quote, News and Overview

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.26  -0.01 (-0.79%)

After market: 1.27 +0.01 (+0.79%)

OPK Quote, Performance and Key Statistics

OPKO HEALTH INC

NASDAQ:OPK (5/23/2025, 8:44:45 PM)

After market: 1.27 +0.01 (+0.79%)

1.26

-0.01 (-0.79%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High2.04
52 Week Low1.19
Market Cap999.24M
Shares793.05M
Float421.79M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-05 2025-08-05/amc
IPO11-02 1995-11-02


OPK short term performance overview.The bars show the price performance of OPK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20

OPK long term performance overview.The bars show the price performance of OPK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of OPK is 1.26 USD. In the past month the price decreased by -10.64%. In the past year, price decreased by -7.35%.

OPKO HEALTH INC / OPK Daily stock chart

OPK Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 11.44 85.67B
CVS CVS HEALTH CORP 9.56 76.79B
LH LABCORP HOLDINGS INC 16.47 20.30B
DGX QUEST DIAGNOSTICS INC 18.63 19.12B
FMS FRESENIUS MEDICAL CARE-ADR 18.25 17.03B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 129.69 14.08B
HIMS HIMS & HERS HEALTH INC 79.46 12.26B
DVA DAVITA INC 14.96 10.62B
CHE CHEMED CORP 24.17 8.33B
CRVL CORVEL CORP 26.4 5.67B
OPCH OPTION CARE HEALTH INC 25.33 5.14B
GH GUARDANT HEALTH INC N/A 4.71B

About OPK

Company Profile

OPK logo image OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 2,997 full-time employees. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Company Info

OPKO HEALTH INC

4400 Biscayne Blvd.

Miami FLORIDA 33137 US

CEO: Phillip Frost

Employees: 2997

OPK Company Website

OPK Investor Relations

Phone: 13055754181

OPKO HEALTH INC / OPK FAQ

What is the stock price of OPKO HEALTH INC today?

The current stock price of OPK is 1.26 USD. The price decreased by -0.79% in the last trading session.


What is the ticker symbol for OPKO HEALTH INC stock?

The exchange symbol of OPKO HEALTH INC is OPK and it is listed on the Nasdaq exchange.


On which exchange is OPK stock listed?

OPK stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for OPKO HEALTH INC stock?

11 analysts have analysed OPK and the average price target is 4.07 USD. This implies a price increase of 223.14% is expected in the next year compared to the current price of 1.26. Check the OPKO HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is OPKO HEALTH INC worth?

OPKO HEALTH INC (OPK) has a market capitalization of 999.24M USD. This makes OPK a Small Cap stock.


How many employees does OPKO HEALTH INC have?

OPKO HEALTH INC (OPK) currently has 2997 employees.


What are the support and resistance levels for OPKO HEALTH INC (OPK) stock?

OPKO HEALTH INC (OPK) has a support level at 1.23 and a resistance level at 1.34. Check the full technical report for a detailed analysis of OPK support and resistance levels.


Is OPKO HEALTH INC (OPK) expected to grow?

The Revenue of OPKO HEALTH INC (OPK) is expected to decline by -4.69% in the next year. Check the estimates tab for more information on the OPK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy OPKO HEALTH INC (OPK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does OPKO HEALTH INC (OPK) stock pay dividends?

OPK does not pay a dividend.


When does OPKO HEALTH INC (OPK) report earnings?

OPKO HEALTH INC (OPK) will report earnings on 2025-08-05, after the market close.


What is the Price/Earnings (PE) ratio of OPKO HEALTH INC (OPK)?

OPKO HEALTH INC (OPK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).


What is the Short Interest ratio of OPKO HEALTH INC (OPK) stock?

The outstanding short interest for OPKO HEALTH INC (OPK) is 11.62% of its float. Check the ownership tab for more information on the OPK short interest.


OPK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

OPK Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OPK. While OPK seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OPK Financial Highlights

Over the last trailing twelve months OPK reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS increased by 45.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.83%
ROE -2.97%
Debt/Equity 0.25
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%-13.7%
EPS 1Y (TTM)45.1%
Revenue 1Y (TTM)-13.78%

OPK Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to OPK. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of -71.77% and a revenue growth -4.69% for OPK


Ownership
Inst Owners29.22%
Ins Owners6.21%
Short Float %11.62%
Short Ratio6.44
Analysts
Analysts83.64
Price Target4.07 (223.02%)
EPS Next Y-71.77%
Revenue Next Year-4.69%